Email Us Here

Delta4 Announces Prof. Doron Lancet To Join Scientific Advisory Board

Delta4, a digital drug discovery company focusing on the identification of new indications for existing drug compounds, recently announced that Prof. Doron Lancet would join its Scientific Advisory Board.